Berenberg analyst Harry Gillis initiated coverage of Moderna (MRNA) with a Hold rating and $42 price target. The firm says mRNA will ...
Shares are trading lower in Europe after gaining in Asia after U.S. stocks recovered somewhat from last week's swoon. Oil ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback